Team:Edinburgh/Introduction/Metal binding
From 2013.igem.org
(Difference between revisions)
Line 6: | Line 6: | ||
We planned to design a system in which a metal binding protein was produced in response to the presence of that metal in the growth medium. As a proof of concept, we chose to work with iron. We planned to use the FUR box and protein to negatively regulate an inverter gene which would then positively regulate expression of an iron binding protein. Thus the more iron that is present, the more iron binding protein is produced. | We planned to design a system in which a metal binding protein was produced in response to the presence of that metal in the growth medium. As a proof of concept, we chose to work with iron. We planned to use the FUR box and protein to negatively regulate an inverter gene which would then positively regulate expression of an iron binding protein. Thus the more iron that is present, the more iron binding protein is produced. | ||
- | We chose as our iron binding protein Ferric binding protein A (FbpA), from ''Neisseria gonorrhoeae''. | + | We chose as our iron binding protein Ferric binding protein A (FbpA), from ''Neisseria gonorrhoeae''. It is a periplasmic protein and a member of the transferrin superfamily, which binds clusters of Fe3+ (Ferreiros ''et al.'' 1999; Alexeev ''et al.'' 2003) |
+ | |||
+ | <h2>References</h2> | ||
Revision as of 18:47, 4 October 2013
We planned to design a system in which a metal binding protein was produced in response to the presence of that metal in the growth medium. As a proof of concept, we chose to work with iron. We planned to use the FUR box and protein to negatively regulate an inverter gene which would then positively regulate expression of an iron binding protein. Thus the more iron that is present, the more iron binding protein is produced.
We chose as our iron binding protein Ferric binding protein A (FbpA), from Neisseria gonorrhoeae. It is a periplasmic protein and a member of the transferrin superfamily, which binds clusters of Fe3+ (Ferreiros et al. 1999; Alexeev et al. 2003)
References
This iGEM team has been funded by the MSD Scottish Life Sciences Fund. The opinions expressed by this iGEM team are those of the team members and do not necessarily represent those of MSD |